
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis
Jasmohan S. Bajaj, K. Rajender Reddy, Jacqueline G. O’Leary, et al.
Gastroenterology (2020) Vol. 159, Iss. 5, pp. 1715-1730.e12
Open Access | Times Cited: 89
Jasmohan S. Bajaj, K. Rajender Reddy, Jacqueline G. O’Leary, et al.
Gastroenterology (2020) Vol. 159, Iss. 5, pp. 1715-1730.e12
Open Access | Times Cited: 89
Showing 1-25 of 89 citing articles:
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 293
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 293
Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 246
Cornelius Engelmann, J. J. Clariá, Gyöngyi Szabó, et al.
Journal of Hepatology (2021) Vol. 75, pp. S49-S66
Open Access | Times Cited: 246
The microbiota in cirrhosis and its role in hepatic decompensation
Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.
Journal of Hepatology (2021) Vol. 75, pp. S67-S81
Open Access | Times Cited: 174
Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.
Journal of Hepatology (2021) Vol. 75, pp. S67-S81
Open Access | Times Cited: 174
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 144
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 144
Acute-on-Chronic Liver Failure Clinical Guidelines
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 137
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 137
ESPEN guideline on chronic intestinal failure in adults – Update 2023
Loris Pironi, Cristina Cuerda, Palle B. Jeppesen, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 10, pp. 1940-2021
Closed Access | Times Cited: 74
Loris Pironi, Cristina Cuerda, Palle B. Jeppesen, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 10, pp. 1940-2021
Closed Access | Times Cited: 74
Promises of microbiome-based therapies
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Jasmohan S. Bajaj, Siew C. Ng, Bernd Schnabl
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1379-1391
Open Access | Times Cited: 71
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 15
Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure
Mireia Casulleras, Ingrid W. Zhang, Cristina López‐Vicario, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2632-2632
Open Access | Times Cited: 100
Mireia Casulleras, Ingrid W. Zhang, Cristina López‐Vicario, et al.
Cells (2020) Vol. 9, Iss. 12, pp. 2632-2632
Open Access | Times Cited: 100
Acute-on-chronic liver failure: A distinct clinical syndrome
Richard Moreau, Bin Gao, Mária Papp, et al.
Journal of Hepatology (2021) Vol. 75, pp. S27-S35
Closed Access | Times Cited: 94
Richard Moreau, Bin Gao, Mária Papp, et al.
Journal of Hepatology (2021) Vol. 75, pp. S27-S35
Closed Access | Times Cited: 94
AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis
Constantine Karvellas, Jasmohan S. Bajaj, Patrick S. Kamath, et al.
Hepatology (2023) Vol. 79, Iss. 6, pp. 1463-1502
Open Access | Times Cited: 35
Constantine Karvellas, Jasmohan S. Bajaj, Patrick S. Kamath, et al.
Hepatology (2023) Vol. 79, Iss. 6, pp. 1463-1502
Open Access | Times Cited: 35
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
M.J.M. de Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
M.J.M. de Koning, Hilde Herrema, Max Nieuwdorp, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Acute-on-chronic liver failure: far to go—a review
Jinjin Luo, Jiaqi Li, Peng Li, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Jinjin Luo, Jiaqi Li, Peng Li, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Gut microbiome and metabolome signatures in liver cirrhosis-related complications
Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 845-862
Open Access | Times Cited: 7
Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 845-862
Open Access | Times Cited: 7
Chronic Liver Diseases and the Microbiome—Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 64
Chathur Acharya, Jasmohan S. Bajaj
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 556-572
Open Access | Times Cited: 64
Mechanisms of immunity in acutely decompensated cirrhosis and acute‐on‐chronic liver failure
Cornelius Engelmann, Ingrid W. Zhang, J. J. Clariá
Liver International (2023)
Open Access | Times Cited: 16
Cornelius Engelmann, Ingrid W. Zhang, J. J. Clariá
Liver International (2023)
Open Access | Times Cited: 16
Metabolic biomarkers significantly enhance the prediction of HBV-related ACLF occurrence and outcomes
Yan Zhang, Wenting Tan, Xianbo Wang, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1159-1171
Closed Access | Times Cited: 16
Yan Zhang, Wenting Tan, Xianbo Wang, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1159-1171
Closed Access | Times Cited: 16
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-associated Cirrhosis
Sidsel Støy, Bernd Schnabl
Gastroenterology Clinics of North America (2025)
Closed Access
Sidsel Støy, Bernd Schnabl
Gastroenterology Clinics of North America (2025)
Closed Access
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis
Jasmohan S. Bajaj, Guadalupe García‐Tsao, K. Rajender Reddy, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2699-2713
Open Access | Times Cited: 39
Jasmohan S. Bajaj, Guadalupe García‐Tsao, K. Rajender Reddy, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2699-2713
Open Access | Times Cited: 39
Serum metabolite profiling yields insights into health promoting effect of A. muciniphila in human volunteers with a metabolic syndrome
Clara Depommier, Amandine Everard, Céline Druart, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Clara Depommier, Amandine Everard, Céline Druart, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
Tilman Sauerbruch, Martin Hennenberg, Jonel Trebicka, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 32
Tilman Sauerbruch, Martin Hennenberg, Jonel Trebicka, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 32
Hepatic triglyceride content is intricately associated with numerous metabolites and biochemical pathways
Tariq Faquih, Jan B. van Klinken, Ruifang Li‐Gao, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1458-1472
Open Access | Times Cited: 13
Tariq Faquih, Jan B. van Klinken, Ruifang Li‐Gao, et al.
Liver International (2023) Vol. 43, Iss. 7, pp. 1458-1472
Open Access | Times Cited: 13
Noninvasive assessment of hepatic decompensation
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 13
Maja Thiele, Stine Johansen, Mads Israelsen, et al.
Hepatology (2023)
Open Access | Times Cited: 13